Quick Answer
NovoCure Ltd reported Total Assets of $804.33 million for fiscal year 2025.
NovoCure Ltd Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $804.33M | -35.2% |
| 2024 | $1.24B | +8.3% |
| 2023 | $1.15B | -3.8% |
| 2022 | $1.19B | +4.6% |
| 2021 | $1.14B | +8.3% |
| 2020 | $1.05B | +119.4% |
| 2019 | $479.45M | +41.1% |
| 2018 | $339.79M | +28.1% |
| 2017 | $265.30M | -5.9% |
| 2016 | $282.08M | -8.2% |
| 2015 | $307.34M | +160.7% |
| 2014 | $117.88M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.36B | +11.4% | +9.3% |
| June 30, 2025 | $1.25B | +2.8% | -0.2% |
| March 31, 2025 | $1.25B | +11.4% | +0.6% |
| December 31, 2024 | $1.24B | +8.3% | +1.5% |
| September 30, 2024 | $1.22B | +6.6% | +0.8% |
| June 30, 2024 | $1.21B | +4.6% | +8.1% |
| March 31, 2024 | $1.12B | -4.5% | -2.2% |
| December 31, 2023 | $1.15B | -3.8% | -0.0% |
- NovoCure Ltd showed a decrease of -35.2% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, NovoCure Ltd’s total assets has grown by 582.3% (from $117.88 million to $804.33 million).
- The most recent figure is from NovoCure Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: